• EZ Cap™ EGFP mRNA (5-moUTP): Cap 1 Capped mRNA for Robust...

  2025-10-26

  EZ Cap™ EGFP mRNA (5-moUTP) is a synthetic capped mRNA construct that enables efficient, stable, and low-immunogenic gene expression of enhanced green fluorescent protein (EGFP) in mammalian cells. Featuring a Cap 1 structure and 5-methoxyuridine modification, this reagent delivers superior translation efficiency and immune evasion compared to unmodified or Cap 0 mRNAs. It is validated for mRNA delivery, translation efficiency assays, and advanced in vivo imaging, setting a new benchmark for functional genomics and translational research.

• Firefly Luciferase mRNA: Next-Gen Reporter for In Vivo Im...

  2025-10-25

  Firefly Luciferase mRNA (ARCA, 5-moUTP) sets a new benchmark in bioluminescent reporting—combining immune evasion, superior stability, and high translational efficiency for gene expression, cell viability, and in vivo imaging assays. Its unique cap and nucleotide modifications deliver robust, sensitive signals and empower advanced experimental workflows, even under challenging storage and delivery conditions.

• 5-Azacytidine: Unlocking Epigenetic Regulation Beyond Can...

  2025-10-24

  Explore the scientific depth of 5-Azacytidine as a DNA methyltransferase inhibitor and epigenetic modulator for cancer research. This article reveals advanced mechanistic insights and novel applications in gene expression regulation, setting it apart from conventional guides.

• Crizotinib Hydrochloride: Illuminating Oncogenic Kinase S...

  2025-10-23

  Explore the transformative impact of Crizotinib hydrochloride in next-generation cancer biology research. This thought-leadership article unites mechanistic insights and strategic guidance—highlighting how advanced assembloid models and ATP-competitive kinase inhibition are redefining translational discovery, drug resistance research, and personalized therapy optimization.

• ARCA Cy5 EGFP mRNA (5-moUTP): Precision Tools for mRNA De...

  2025-10-22

  ARCA Cy5 EGFP mRNA (5-moUTP) revolutionizes mRNA delivery research by enabling real-time, dual-mode tracking of both transcript localization and translation efficiency in mammalian cells. Its unique combination of 5-methoxyuridine modification and Cyanine 5 labeling empowers researchers to troubleshoot delivery bottlenecks and optimize transfection protocols with quantitative confidence.

• Decoding Lipid Peroxidation: Strategic Advances for Trans...

  2025-10-21

  Translational researchers face a pivotal challenge in quantifying oxidative stress and unraveling the intricacies of lipid peroxidation across disease models. This thought-leadership article delivers a mechanistic deep dive into the centrality of malondialdehyde (MDA) as a biomarker, the evolving understanding of ferroptosis in cancer resistance, and the strategic imperatives for translational research. Drawing on recent breakthroughs in clear cell renal cell carcinoma and leveraging the unique capabilities of the Lipid Peroxidation (MDA) Assay Kit, we set a new standard for precision, clinical relevance, and innovation in oxidative stress biomarker research.

• Lipid Peroxidation (MDA) Assay Kit: Precision Oxidative S...

  2025-10-20

  Unlock the full research potential of the Lipid Peroxidation (MDA) Assay Kit with robust, reproducible workflows and troubleshooting strategies for malondialdehyde quantification. This guide bridges bench techniques with translational insights, empowering studies of ferroptosis, drug resistance, and oxidative damage across disease models.

• From Mechanism to Medicine: Strategic Innovation in Lipid...

  2025-10-19

  This thought-leadership article explores how cutting-edge malondialdehyde (MDA) quantification, via the Lipid Peroxidation (MDA) Assay Kit, is revolutionizing translational research. Bridging rigorous mechanistic insight into lipid peroxidation, experimental best practices, and the evolving needs of clinical innovation, it synthesizes emerging evidence from oncology—including recent advances in understanding ferroptosis and drug resistance in clear cell renal cell carcinoma (ccRCC)—with actionable guidance for the next generation of oxidative stress biomarker research.

• From Mechanism to Medicine: Advancing Translational Resea...

  2025-10-18

  Explore how mechanistic insight into lipid peroxidation and ferroptosis is transforming translational research. This thought-leadership article integrates biological rationale, experimental strategy, and clinical vision—highlighting the strategic use of the Lipid Peroxidation (MDA) Assay Kit for quantifying malondialdehyde (MDA), benchmarking oxidative stress, and advancing biomarker-driven innovation in drug resistance and disease modeling.

• EZ Cap™ Cas9 mRNA (m1Ψ): Engineering Precision via RNA Mo...

  2025-10-17

  Explore how EZ Cap™ Cas9 mRNA (m1Ψ) leverages advanced mRNA engineering—including Cap1 structure, N1-Methylpseudo-UTP, and poly(A) tail—to enable highly precise, temporally controlled CRISPR-Cas9 genome editing. This article uniquely examines the intersection of mRNA structure, nuclear export, and specificity, offering insights not covered elsewhere.

• Translational Precision in Gene Expression: Mechanistic I...

  2025-10-16

  This thought-leadership article explores the mechanistic, experimental, and translational frontiers of first-strand cDNA synthesis from total RNA, emphasizing how innovations in reverse transcription—exemplified by the HyperScript™ First-Strand cDNA Synthesis Kit—enable researchers to overcome complex RNA secondary structures and low-abundance targets. Drawing on current scientific literature, including pivotal studies in leukemia, and positioning these insights within a competitive and clinical context, the article offers actionable strategies and a forward-looking perspective for translational researchers seeking robust gene expression analysis.

• NVP-BHG712 It has been suggested that the suppression

  2023-07-06

  

  It has been suggested that the suppression of 5-LOX could promote apoptotic signaling pathways in cancers [6]. However, the role of 5-LOX in modulating apoptotic factors and neutrophil activation during ANP has not yet been evaluated. In this study, we aimed to evaluate the expression of 5-LOX in p

• Herein we disclose novel dihydropyrano c pyrazoles that inhi

  2023-07-06

  

  Herein, we disclose novel 2,4-dihydropyrano[2,3-c]pyrazoles that inhibit human ATX (hATX). Our results demonstrate and further support previous findings showing that a desired biological action can be achieved without targeting the catalytic site of the enzyme. Moreover, this study validated hen egg

• br Author contributions br Competing interests br

  2023-07-06

  

  Author contributions Competing interests Transparency document Acknowledgments This research was funded by a TOP ZonMW grant (40-00812-98-10054) to R.O.E., a DFG grant (KR4391/1-1) and IZKF Erlangen grant (J36) to A.K. and supported in part by Centro de Investigación Biomédica en Red de

• Although plant Aurora kinases can be clearly grouped

  2023-07-05

  

  Although plant Aurora kinases can be clearly grouped into functional clades, the roles of the respective clades does not seem to be evolutionarily conserved. AtAurora 1 labels kinetochore microtubules [19], similarly to mammalian Aurora A, while its targeting to the cell plate resembles features of

11212 records 17/748 page Previous Next First page 上5页 1617181920 下5页 Last page